{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:22:10Z","timestamp":1767824530551,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T00:00:00Z","timestamp":1181260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2007,10,12]]},"DOI":"10.1007\/s11864-007-0015-3","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T15:10:57Z","timestamp":1181229057000},"page":"97-108","source":"Crossref","is-referenced-by-count":5,"title":["Outline for Writing an Article for Current Treatment Options in Oncology: Splenic Lymphoma with Villous Lymphocytes"],"prefix":"10.1007","volume":"8","author":[{"given":"Xavier","family":"Troussard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Cornet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,8]]},"reference":[{"key":"15_CR1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jcp.40.6.642","volume":"40","author":"JV Melo","year":"1987","unstructured":"Melo JV, Hegde U, Parreira A, et\u00a0al. (1987) Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with a large spleens. J Clin Pathol 40:642\u2013651","journal-title":"J Clin Pathol"},{"key":"15_CR2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","volume":"78","author":"SP Mulligan","year":"1991","unstructured":"Mulligan SP, Matutes E, Dearden C, Catovsky D (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol 78:206\u2013209","journal-title":"Br J Haematol"},{"key":"15_CR3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","volume":"93","author":"X Troussard","year":"1996","unstructured":"Troussard X, Valensi F, Duchayne E, et\u00a0al. (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Br J Haematol 93:731\u2013736","journal-title":"Br J Haematol"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","volume":"95","author":"F Berger","year":"2000","unstructured":"Berger F, Felman P, Thieblemont C, et\u00a0al. (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95:1950\u20131956","journal-title":"Blood"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","volume":"100","author":"JI Chacon","year":"2002","unstructured":"Chacon JI, Mollejo M, Munoz E, et\u00a0al. (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 100:1648\u20131654","journal-title":"Blood"},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","volume":"3","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont C, Felman P, Berger F, et\u00a0al. (2002) Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 3: 41\u201347","journal-title":"Clin Lymphoma"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","volume":"120","author":"N Parry-Jones","year":"2003","unstructured":"Parry-Jones N, Matutes E, Gruszka-Westwood AM, et\u00a0al. (2003) Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol 120:759\u2013764","journal-title":"Br J Haematol"},{"key":"15_CR8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.20596","volume":"101","author":"E Iannitto","year":"2004","unstructured":"Iannitto E, Ambrosetti A, Ammatuna E, et\u00a0al. (2004) Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients. Cancer 101:2050\u20132057","journal-title":"Cancer"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N, et\u00a0al. (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 107: 4643\u20134649","journal-title":"Blood"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2141.2003.04449.x","volume":"122","author":"J Audouin","year":"2003","unstructured":"Audouin J, Le Tourneau A, Molina T, et\u00a0al. (2003) Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol.122:404\u2013412","journal-title":"Br J Haematol"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-0609.2005.00624.x","volume":"76","author":"A Pich","year":"2006","unstructured":"Pich A, Fraire F, Fornari A, Bonino LD, et\u00a0al. (2006) Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study. Eur J Haematol.76:392\u2013398","journal-title":"Eur J Haematol"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","volume":"84","author":"PG Isaacson","year":"1994","unstructured":"Isaacson PG, Matutes E, Burke M, Catovsky D (1994) The histo-pathology of splenic lymhoma with villous lymphocytes. Blood 84:3828\u20133834","journal-title":"Blood"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","volume":"83","author":"E Matutes","year":"1994","unstructured":"Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D (1994) The immunophenotype of splenic lymphoma with villous lymhocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 83:1558\u20131562","journal-title":"Blood"},{"key":"15_CR14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0145-2126(95)00165-4","volume":"20","author":"F Salomon-Nguyen","year":"1996","unstructured":"Salomon-Nguyen F, Valensi F, Troussard X, Flandrin G (1996) The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders. Leuk Res 20:909\u2013913","journal-title":"Leuk Res"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1993.tb03337.x","volume":"85","author":"DG Oscier","year":"1993","unstructured":"Oscier DG, Matutes E, Gardiner A, et\u00a0al. (1993) Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol 85:487\u2013491","journal-title":"Br J Haematol"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2141.1998.00764.x","volume":"101","author":"X Troussard","year":"1998","unstructured":"Troussard X, Mauvieux L, Radford-Weiss I., et\u00a0al. (1998) Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Fran\u00e7ais d\u2019 H\u00e9matologie Cellulaire (GFHC) study. Br J Haematol 101:712\u2013721","journal-title":"Br J Haematol"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.1999.01209.x","volume":"104","author":"AM Gruszka-Westwood","year":"1999","unstructured":"Gruszka-Westwood AM, Matutes E, Coignet LJA, Wotherspoon A, Catovsky D (1999) The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. Br J Haematol 104:600\u2013604","journal-title":"Br J Haematol"},{"key":"15_CR18","doi-asserted-by":"crossref","unstructured":"Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D: Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer 2003, 36:57\u201369. Erratum in: GenesChromosomes Cancer 2004, 39:170.","DOI":"10.1002\/gcc.10142"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","volume":"97","author":"AM Gruszka-Westwood","year":"2001","unstructured":"Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D (2001) p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 97:3552\u20133558","journal-title":"Blood"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-4608(96)00265-8","volume":"96","author":"SM Morgan","year":"1997","unstructured":"Morgan SM, Roberts SH, Thompson PW, De Alwis C (1997) Isochromosomes of both short and long arms of chromosome 12 resulting in an additional copy of chromosome 12 in a cas of splenic lymphoma with villous lymphocytes. Cancer Genet Cytogenet 96:13\u201316","journal-title":"Cancer Genet Cytogenet"},{"key":"15_CR21","first-page":"1736","volume":"58","author":"JA Garcia-Marco","year":"1998","unstructured":"Garcia-Marco JA, Nouel A, Navarro B, et\u00a0al. (1998) Molecular cytogenetic analysis in splenic lymhoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14. Cancer Res 58:1736\u20131740","journal-title":"Cancer Res"},{"key":"15_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2004.03.002","volume":"19","author":"D Oscier","year":"2005","unstructured":"Oscier D, Owen R, Johnson S (2005) Splenic marginal zone lymphoma. Blood Rev 19:39\u201351","journal-title":"Blood Rev"},{"key":"15_CR23","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","volume":"103","author":"C Thieblemont","year":"2004","unstructured":"* Thieblemont C, Nasser V, Felman P, et\u00a0al. (2004) Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 103:2727\u20132737","journal-title":"Blood"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood.V98.9.2837","volume":"98","author":"T Sonoki","year":"2001","unstructured":"Sonoki T, Harder L, Horsman DE, et\u00a0al. (2001) Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 98:2837\u20132844","journal-title":"Blood"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.21348","volume":"118","author":"M Daibata","year":"2006","unstructured":"Daibata M, Taguchi T, Nemoto Y, Iwasaki S, Ohtsuki Y, Taguchi H (2006) In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes. Int J Cancer 118:513\u2013517","journal-title":"Int J Cancer"},{"key":"15_CR26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V85.6.1603.bloodjournal8561603","volume":"85","author":"D Zhu","year":"1995","unstructured":"Zhu D, Oscier DG, Stevenson FK (1995) Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. Blood 85:1603\u20131607","journal-title":"Blood"},{"key":"15_CR27","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2002-01-0169","volume":"100","author":"D Zhu","year":"2002","unstructured":"Zhu D, Orchard J, Oscier DG, Wright DH, Stevenson FK (2002) V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. Blood 100:2659\u20132661","journal-title":"Blood"},{"key":"15_CR28","first-page":"470","volume":"90","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Davi F, Ben Simon E, et\u00a0al. (2005) Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 90:470\u2013478","journal-title":"Haematologica"},{"key":"15_CR29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0609.2005.00578.x","volume":"76","author":"E Iannitto","year":"2006","unstructured":"Iannitto E, Minardi V, Callea V, et\u00a0al (2006) Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. Eur J Haematol. 76:134\u2013140","journal-title":"Eur J Haematol"},{"key":"15_CR30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/jcp.45.12.1111","volume":"45","author":"I Ribeiro","year":"1992","unstructured":"Ribeiro I, Costa MM, Fernandes BA, Sousa I, Melo A, Parreira A, Uva LS (1992) Splenic lymphoma with villous lymphocytes in two sisters. J Clin Pathol 45:1111\u20131113","journal-title":"J Clin Pathol"},{"key":"15_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0140-6736(92)92108-R","volume":"340","author":"I Bates","year":"1992","unstructured":"Bates I, Bedu-Addo G, Rutherford T, Bevan DH (1992) Splenic lymphoma with villous lymphocytes in tropical west africa. Lancet 340:75\u2013577","journal-title":"Lancet"},{"key":"15_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0035-9203(97)90211-X","volume":"91","author":"I Bates","year":"1997","unstructured":"Bates I, Bedu-Addo G, Rutherford TR, Bevan DH (1997) Circulating villous lymphocytes \u2013 a link between hyperreactive malarial splenomegaly and splenic lymphoma. Transactions of the Royal Society of Tropical Medicine and Hygiene 91:171\u2013174","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"15_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefrere F, Bronowicki JP, et\u00a0al. (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347: 89\u201394","journal-title":"N Engl J Med"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","volume":"105","author":"D Saadoun","year":"2005","unstructured":"Saadoun D, Suarez F, Lefrere F, et\u00a0al. (2005) Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 105:74\u201376","journal-title":"Blood"},{"key":"15_CR35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1532\/IJH97.E0434","volume":"81","author":"M Hansson","year":"2005","unstructured":"Hansson M, Linde A, Olsson I (2005) Reactivation of latent Epstein Barr Virus infection induces remission of splenic lymphoma with villous lymphocytes. Int J Hematol 81:413\u2013416","journal-title":"Int J Hematol"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.1365-2141.1998.1161f.x","volume":"103","author":"A El Weshi","year":"1998","unstructured":"El Weshi A, Ribrag V, Girinski T, et\u00a0al. (1998) Low and medium dose spleen radiation therapy are able to induce long-term responses in splenic lymphoma with villous lymphocytes. Br J Haematol 103:1212\u20131213","journal-title":"Br J Haematol"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","volume":"14","author":"F Lefrere","year":"2000","unstructured":"Lefrere F, Hermine O, Belanger C, et\u00a0al. (2000) Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes. Leukemia 14:573\u2013575","journal-title":"Leukemia"},{"key":"15_CR38","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/sj.leu.2403440","volume":"18","author":"F Lefrere","year":"2004","unstructured":"Lefrere F, Levy V, Francois S, et\u00a0al. (2004) Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update. Leukemia 18:1924\u20131925","journal-title":"Leukemia"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1997.3523168.x","volume":"99","author":"S Bolam","year":"1997","unstructured":"Bolam S, Orchard J, Oscier D (1997) Fludarabine is effective in the treatment of splenic lymphoma with villouis lymphocytes. Br J Haematol 99:158\u2013161","journal-title":"Br J Haematol"},{"key":"15_CR40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-0609.2002.02759.x","volume":"69","author":"M Yasukawa","year":"2002","unstructured":"Yasukawa M, Yamauchi H, Azuma T, et\u00a0al. (2002) Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes. Eur J Haematol 69:112\u2013114","journal-title":"Eur J Haematol"},{"key":"15_CR41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0609.2005.00426.x","volume":"75","author":"E Iannitto","year":"2005","unstructured":"Iannitto E, Minardi V, Calvaruso G, et\u00a0al. (2005) Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes. Eur J Haematol 75:130\u2013135","journal-title":"Eur J Haematol"},{"key":"15_CR42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","volume":"40","author":"F Lefrere","year":"2000","unstructured":"Lefrere F, Hermine O, Francois S, et\u00a0al. (2000) Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes. Leukemia Lymphoma 40:113\u2013117","journal-title":"Leukemia Lymphoma"},{"key":"15_CR43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1998.0636f.x","volume":"100","author":"A Virchis","year":"1998","unstructured":"Virchis A., Mehta A (1998) Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyad\u00e9nosine (2-CdA). Br J Haematol 100:605\u2013618","journal-title":"Br J Haematol"},{"key":"15_CR44","first-page":"134","volume":"98","author":"D Thomas","year":"2001","unstructured":"Thomas D, O\u2019Brian S, Cotes J, et\u00a0al. (2001) Treatment of splenic lymphoma with villous lymphocytes (SLVL) and marginal zone lymphoma with single agent Rituximab. Blood 98:134a","journal-title":"Blood"},{"key":"15_CR45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1182\/blood.V100.1.312","volume":"100","author":"J Daniels","year":"2002","unstructured":"Daniels J, Perkins J, Byrd J (2002) Rituximab is effective for patients with splenic lymphoma with villous lymphocytes. Blood 100:312b","journal-title":"Blood"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-007-0015-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-007-0015-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-007-0015-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T21:13:58Z","timestamp":1587590038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-007-0015-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10,12]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s11864-007-0015-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,8]]}}}